Confidence From the Start

The first and only closed-loop SCS system powered by objective neural data to deliver predictable, durable pain relief from day one.

Evoke System closed-loop spinal cord stimulation with Eva Sensing Technology

Meet the Evoke® System

Disrupting pain by removing guesswork.

Listen to the spinal cord, not the representative
The dose is anchored to each patient’s individual physiology – unlike others that are set subjectively by the programmer.
Therapy is individually calibrated from the start
Objectively scans and analyzes each patient’s unique spinal cord to identify therapeutic settings from day one of the trial phase.
Automatically adjusts to maintain consistent pain relief
Continual adjustments address both over AND under dosing for sustainable, predictable pain relief.

Evoke System IPG implantable pulse generator for spinal cord stimulation therapy

Objective by Design

EVA™ Sensing Technology identifies personalized therapeutic settings. SmartLoop® Technology maintains it.

At the touch of a button, EVA™ Sensing Technology objectively scans and analyzes each patient’s spinal cord to identify the therapeutic dose at a level beyond human capability.

SmartLoop^® technology maintains the identified therapeutic dose by continuously auto-adjusting on every pulse, over 4+ million times a day*, to deliver consistent pain relief with every heartbeat, breath, and movement.

Redefining Spinal Cord Stimulation

That WasThen

Fixed-Output SCS:

Unknown and inconsistent dosing

Cannot auto-adjust for movement and
physiological changes throughout the day

fixed output spinal cord stimulation

This IsNow

Known and consistent dosing

Automatically adjusts in real time to maintain consistent activation across activities

Evoke Therapy Closed loop spinal cord stimulation

Know the Whole Story

Introducing the Evoke™ Therapy Report

Subjective feedback tells half the story. Only the Evoke™ Therapy report provides physiological insights along with patient reported outcomes, empowering clinicians to make more informed clinical decisions.

Therapy Report for Evoke Therapy closed‑loop spinal cord stimulation for chronic pain

PROVEN EVIDENCE

Proven in Practice

Backed by the landmark EVOKE Study—The only SCS therapy with double-blinded RCT evidence with 36-month outcomes.¹

0 %

of patients are pain responders (≥50% VAS reduction)

0 %

of patients are high-pain responders (≥80% VAS reduction)

0 %

of three month responders were still responders at three years

0

closed-loop explants due to loss of efficacy

Disrupting the SCS Market

The Evoke® System is redefining what’s possible in spinal cord stimulation.

	Evoke® System with Smartloop® Technology	Other Closed-Loop SCS Therapies	Fixed-Output SCS Therapies
Clinical Superiority Proven Out to 36-Months	✓¹	X	X
Senses ECAPs	✓	✓	X
Sets Target ECAP Dose	✓	X² Uses ECAPs to React to Overstimulation	X
Percent of Time Actively Adjusting	100%	<10%³	X
Controls for Overdosing	✓	X ~46% of Patients Still Experience Overstimulation⁴	X
Controls for Underdosing	✓	X⁴	X
Ability to Sense and Respond in the Trial Evaluation	✓	X	X
Ability to Drive with Closed-Loop Therapy	✓	X⁵	X
Full-Body MRI Conditional Labeling	✓⁶	✓⁷	✓

Have questions?

Connect with us to learn how the Evoke® System can become a valuable part of your practice.

Looking for Resources?

Looking for brochures, MRI guidelines, or other materials?
Explore our library of resources.